Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-3-11
pubmed:abstractText
Vascular endothelial cells are primary targets for injury during both cellular and humoral allograft rejection (AR). In cardiac transplantation, the role of humoral immunity in mediating AR has not been extensively characterized.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
385-91
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10030283-Adolescent, pubmed-meshheading:10030283-Adult, pubmed-meshheading:10030283-Aged, pubmed-meshheading:10030283-Antibody Formation, pubmed-meshheading:10030283-Cells, Cultured, pubmed-meshheading:10030283-Endothelium, Vascular, pubmed-meshheading:10030283-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:10030283-Female, pubmed-meshheading:10030283-Follow-Up Studies, pubmed-meshheading:10030283-Graft Rejection, pubmed-meshheading:10030283-Graft Survival, pubmed-meshheading:10030283-Heart Transplantation, pubmed-meshheading:10030283-Humans, pubmed-meshheading:10030283-Immunity, Cellular, pubmed-meshheading:10030283-Isoantibodies, pubmed-meshheading:10030283-Male, pubmed-meshheading:10030283-Middle Aged, pubmed-meshheading:10030283-Reference Values, pubmed-meshheading:10030283-Time Factors, pubmed-meshheading:10030283-Umbilical Veins
pubmed:year
1999
pubmed:articleTitle
The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.
pubmed:affiliation
Department of Pediatrics, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, California 90048, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't